Search results
Black Diamond Therapeutics Inc (BDTX) Reports Q4 and Full Year 2023 Financials, Advances ...
GuruFocus.com via Yahoo Finance· 3 months agoFinancial Position: Black Diamond Therapeutics ended 2023 with $131.4 million in cash, cash equivalents, and investments. R&D Expenses: R&D expenses decreased to $59.4 million in 2023 from $64.4 ...